Tableau > Case Studies > Faster, Easier, and Friendlier Analysis of Virus Research and Treatment

Faster, Easier, and Friendlier Analysis of Virus Research and Treatment

Tableau Logo
Company Size
1,000+
Region
  • Europe
Country
  • France
Product
  • Tableau Software
Tech Stack
  • Data Visualization
  • Big Data Analysis
Implementation Scale
  • Departmental Deployment
Impact Metrics
  • Innovation Output
  • Productivity Improvements
Technology Category
  • Analytics & Modeling - Big Data Analytics
  • Application Infrastructure & Middleware - Data Visualization
Applicable Industries
  • Healthcare & Hospitals
  • Life Sciences
Applicable Functions
  • Product Research & Development
Use Cases
  • Predictive Maintenance
Services
  • Data Science Services
About The Customer
The Commissariat à l’Energie Atomique (CEA, the French Alternative Energies and Atomic Energy Commission) is a French government-funded technology research organization and a prominent player in the European research arena. CEA, working with its partner Mydral, has standardized on Tableau in its Life Sciences division to accelerate and streamline the reporting and analysis of viral infections such as AIDS, and emerging diseases like influenza, dengue and Chikungunya. The organization’s mission is to explore and develop vaccine treatment strategies for chronic and emerging viral infections.
The Challenge
The immunovirology division of the CEA in Fontenayaux-Roses was facing a challenge in gaining a rapid visual understanding of its investigations. The organization’s mission is to explore and develop vaccine treatment strategies for chronic and emerging viral infections. However, the research groups relied on different and fragmented silos of research data. This led to the team devoting unnecessary time to compiling the data reporting—as opposed to actually analysing the data and experimenting with models to combat viruses. Antonio Cosma, a research scientist responsible of the FlowCyTech core of the CEA’s division of immuno-virology explains, “Our research was held up in the slow lane because we had to collect the data, and then prepare and adapt the spread sheets. After that, we then devoted hours to creating visually appealing graphs and bar charts to show the results.”
The Solution
CEA, with its partner Mydral, standardized on Tableau in its Life Sciences division to accelerate and streamline the reporting and analysis of viral infections. Tableau was installed as a trial by Antonio Cosma, a research scientist responsible for the FlowCyTech core of the CEA’s division of immuno-virology. Within minutes he was supporting his flow cytometry analysis and cell sorting with visual reporting. The cytometry platform examines, counts, and sorts up to 50,000 fluorescence-tagged cells per second, and is used to separate cells of interest to the CEA research team. Using Tableau, the CEA team integrates the vast amount of research data collected by the flow cytometry into a single visual analysis process. This allows Antonio Cosma and his team to quickly see patterns in their data and shift views instantly to follow their line of research.
Operational Impact
  • Tableau is transforming the way CEA looks at and analyzes research data.
  • CEA team can instantly visualize the information in a multitude of different ways.
  • Tableau points CEA immediately to which antibody is the most appropriate for the test, its reference, and its history.
  • Tableau makes the volume of big data transparent and answers questions immediately.
Quantitative Benefit
  • Big data analysis is now quick and commonplace, with compelling visual reports available anywhere in the research organization within minutes, compared with days or even weeks previously.
  • The cytometry platform examines, counts, and sorts up to 50,000 fluorescence-tagged cells per second.

Case Study missing?

Start adding your own!

Register with your work email and create a new case study profile for your business.

Add New Record

Related Case Studies.

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.